FDA Inspection 1165668 — University Of Oklahoma Health Science Center IRB
The FDA completed an inspection of University Of Oklahoma Health Science Center IRB on Mar 18, 2022 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
IRB